Materias dentro de su búsqueda.
Mostrando 1,042,361 - 1,042,380 Resultados de 1,045,414 Para Buscar '"The Times"', tiempo de consulta: 5.58s Limitar resultados
  1. 1042361
    “…We will also explore whether participant engagement, as measured by paradata (data collected as users interact with an mHealth intervention, eg, time spent using the intervention), mediates stigma- and HIV care–related outcomes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Increasing HIV Testing and Viral Suppression via Stigma Reduction in a Social Networking Mobile Health Intervention Among Black and Latinx Young Men and Transgender Women Who Have Sex With Men (HealthMpowerment): Protocol for a Randomized Controlled Trial
  2. 1042362
    “…Interaction terms were added to assess effect modification by age, sex, ethnicity, comorbidities, and calendar time. RESULTS: 17 282 905 adults were included, of whom 27 480 (0·16%) had HIV recorded. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform
  3. 1042363
    “…Martina Kovac, MD, GSK (Other Financial or Material Support, I was an employee of GSK at the time of the study) Anthony L. Cunningham, MBBS, MD, FRACP, FRCPA, GSK (Consultant) Srikanth Emmadi, MSc, GSK (Employee) Keith Sullivan, MD, FASTCT, GSK (Consultant) Alemnew F. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    7. Can Recombinant Zoster Vaccine Administration Decrease the Use of Herpes Zoster-related Pain Medication Across Randomized Controlled Studies?
  4. 1042364
    “…Of the 11 on F/TDF, 10 had low, 0 had medium, and 1 had high TFV-DP levels; among HIV-negative controls, 5% of the person-time had low, 9% had medium, and 86% had high TFV-DP levels. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    999. Using the F/TDF Adherence-Efficacy Relationship to Calculate Background HIV incidence: Results from the DISCOVER trial
  5. 1042365
    “…Figure 3 Risk of recurrent CMV infection in the 6 months following clearance and stopping of treatment for the first CMV infection (N=99), stratified by CMV serostatus at the time of transplant [Image: see text] Figure 4 Factors associated with recurrent CMV infection within 6 months of stopping treatment for the first CMV infection [Image: see text] CONCLUSION: Recurrent CMV infection remains a significant complication among SOT recipients, especially in those with high risk CMV IgG serostatus. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1079. The Risk of Cytomegalovirus (CMV) Infection and Recurrence Among Solid Organ Transplant Recipients
  6. 1042366
    “…Traditional surveillance detection was defined as the time of outbreak detection by routine infection control procedures. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    877. Use of Statistical Process Control Charts for Early Detection of Healthcare Facility-Associated Nontuberculous Mycobacterial Outbreaks
  7. 1042367
    “…A previous analysis found variability in the timing of HepB doses in infants receiving DTaP-IPV/Hib. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1393. Factors Associated with Co-administration of Pentavalent DTaP-IPV/Hib and Monovalent Hepatitis B Vaccine in the United States (US)
  8. 1042368
    “…We also used a generalized linear model to determine adjusted TR stratified by the presence or absence of any acute or chronic graft-versus-host diseases (GVHD) after adjusting for age, health plan, underlying disease, stem cell source, number of comorbidities, baseline costs, and follow-up time. RESULTS: The study included 13,363 patients, representing 22% of HCTs reported to CIBMTR for the study period, of which 1,368 (10%) were coded with an RVI in the year following HCT: 578 (4%) RSV, 687 (5%) influenza, 166 (1%) PIV, and 181 (1%) HMPV. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    195. Economic and Clinical Burden of Respiratory Virus Infections in Allogeneic Hematopoietic Cell Transplantation Recipients
  9. 1042369
    “…Correlates such as the ASCVD score should be considered in the timing of HCV treatment, in order to reduce the long-term risk of CVD. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1067. Interferon-free Hepatitis C Treatment Increases Surrogates of Cardiovascular Disease Risk in Black Veterans
  10. 1042370
    “…METHODS: Sparse pharmacokinetic (PK) samples at steady state from critically ill patients with pneumonia, bloodstream infection/sepsis, or complicated urinary tract infection receiving CFDC in two Phase 3 studies were analyzed. Percent time of dosing interval of free drug concentration exceeding the minimum inhibitory concentration (MIC) in plasma and epithelial lining fluid (ELF) (%fT(>MIC) and %fT(>MIC,ELF), respectively) were determined for 60 (CREDIBLE-CR; NCT02714595) and 97 patients (APEKS-NP; NCT03032380), using a 3-compartment population PK model. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients
  11. 1042371
    “…[Image: see text] METHODS: Previously healthy children < 2 years old with mild (outpatients) and severe (inpatients) RSV infection were enrolled and nasopharyngeal swabs were obtained for RSV typing and quantitation by real-time PCR. Patients were stratified by age (0-< 3, 3-6, and >6-24 months) and multivariable analyses were performed to identify clinical and viral factors associated with severe disease. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1465. Age-Dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection (RSV) Infection
  12. 1042372
    “…Guidelines changed over time. Hydroxychloroquine (HCQ) was unrestricted during phase 1, then restricted by pharmacy outside of a randomized clinical trial (RCT) during phase 2 (excepting those ineligible for RCTs). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    555. Effectiveness of a Treatment Team on Adherence to Health System Guidelines for Hydroxychloroquine Use During Two Phases of the COVID-19 Epidemic
  13. 1042373
    “…More effectiveness studies are warranted to further address questions on the relationship of VE and time since vaccination as well as the effectiveness of a third dose of M-M-R(®) II for measles or mumps outbreak control. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1390. Effectiveness of M-M-R(®) II in outbreaks - a systematic literature review of real-world observational studies
  14. 1042374
    “…For many hospitals, SSI surveillance has three main objectives: to feedback surgeons with their SSI rates; to evaluate SSI rates over time, identifying outbreaks; and to compare data among different institutions. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    891. Is Post-discharge Surveillance of Surgical Patients Really Worth It? Results Observed in Three Years of a Multicenter Study
  15. 1042375
    “…Diaries were reviewed with subjects on return. Primary endpoint was time to first unformed stool (TFUS) in a TD episode. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    632. A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial Evaluating Two Dose Regimens of Rifaximin (550mg daily or twice-daily) for Chemoprophylaxis Against Travelers’ Diarrhea Among Deployed U.S. and U.K. Military Personnel (PREVENT TD)
  16. 1042376
    “…RESULTS: AOM IRs declined over time among commercially and Medicaid-insured children in all age groups < 18 years old. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1479. Incidence of Acute Otitis Media in Children in the United States before and after the introduction of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) during 1998-2018
  17. 1042377
    “…Nasal/throat swabs were collected from emergency department (ED) or inpatient children with ARI, or healthy controls in clinic, between 12/05/2016-10/31/2019 and tested by real-time RT-PCR for ICV and other respiratory viruses. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1714. Influenza C Virus in U.S. Children with Acute Respiratory Infection 2016-2019
  18. 1042378
    “…We used three datasets to validate our models: the Office for National Statistics (ONS) Community Infection Survey, the Real-time Assessment of Community Transmission (REACT-1) study, and UK Government testing data. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Detecting COVID-19 infection hotspots in England using large-scale self-reported data from a mobile application: a prospective, observational study
  19. 1042379
    “…Hierarchical linear modeling was utilized to compare pre- and post-treatment immune cell expression, account for correlation of time-dependent measurement, variation across high-powered magnification views within each subject, and variation between subjects. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer
  20. 1042380
    “…Treatment with empagliflozin had no effect on the primary endpoint of systemic vascular resistance index, nor on cardiac index, stroke volume index or pulse rate at any time point. In addition, echocardiography showed no difference in left ventricular systolic function as assessed by left ventricular ejections fraction and strain analysis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Empagliflozin does not change cardiac index nor systemic vascular resistance but rapidly improves left ventricular filling pressure in patients with type 2 diabetes: a randomized controlled study
Herramientas de búsqueda: RSS